Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel RANKL inhibitor reduces bone resorption in vivo

June 12, 2012

Novel results disclosed on GLP-1 receptor agonist ZYOG-1

June 11, 2012

Clinical trials reveal efficacy of albiglutide in treating diabetes

June 11, 2012

Clinical and preclinical results on tofogliflozin presented at ADA meeting

June 11, 2012

ORCA Therapeutics' lead product set to enter clinic

June 11, 2012

MABEL dose set for NKG2-A-directed monoclonal antibody

June 11, 2012

Researchers describe novel monovalent CD28-targeted Fab' antibody fragment

June 8, 2012

Ongoing EULAR conference features long-term adalimumab efficacy data in spondylarthritis

June 8, 2012

AX-01128 protects kidney transplant function in vivo

June 8, 2012

AstraZeneca TLR7 agonist assessed in four clinical trials

June 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...